Overview

A Study Evaluating Soticlestat in Participants With Dravet Syndrome or Lennox-Gastaut Syndrome Who Have Been Exposed to Fenfluramine

Status:
TERMINATED

Trial end date:
2024-08-14

Target enrollment:

Participant gender:

Summary

The purpose of this study is to check how soticlestat impacts symptoms of Dravet syndrome \[DS\] and Lennox-Gastaut syndrome \[LGS\] in participants who have been exposed to fenfluramine.

Phase:

PHASE3

Details

Lead Sponsor:

Takeda

Treatments:

soticlestat